WGRX vs MSFT: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

MSFT has stronger fundamentals based on our AI analysis.

WGRX
Wellgistics Health, Inc.
STRONG SELL
97%
Confidence
VS
MSFT
MICROSOFT CORP
BUY
91%
Confidence

WGRX vs MSFT Fundamental Comparison

Metric WGRX MSFT
Revenue $23.3M $241.8B
Net Income $-101.3M $98.0B
Net Margin -433.9% 40.5%
ROE N/A 23.6%
ROA -332.5% 14.1%
Current Ratio 0.09x 1.28x
Debt/Equity N/A 0.10x
EPS $-1.43 $13.14

Green = Better metric | Red = Weaker metric

View Full WGRX Analysis →
View Full MSFT Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

WGRX vs AAPL MSFT vs GOOGL WGRX vs AMZN MSFT vs NVDA

WGRX vs MSFT: Frequently Asked Questions

Is WGRX or MSFT a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. WGRX is rated STRONG SELL (97% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.

How does WGRX compare to MSFT fundamentally?

Wellgistics Health, Inc. has ROE of N/A vs MICROSOFT CORP's 23.6%. Net margins are -433.9% vs 40.5% respectively.

Which stock pays higher dividends, WGRX or MSFT?

WGRX has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in WGRX or MSFT for long term?

For long-term investing, consider that WGRX has STRONG SELL rating with 97% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about WGRX vs MSFT?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For WGRX vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.